Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cerebain Biotech Corp. (OTC: CBBT).

Full DD Report for CBBT

You must become a subscriber to view this report.

Recent News from (OTC: CBBT)

Cerebain's Strategic Partner Adds Key Personnel to Accelerate Advancement of Device Development
Cerebain Biotech (OTCQB: CBBT) today announced that the company’s strategic partner, Sonos Models, Inc., has added key personnel to its staff to facilitate the acceleration in development of the company’s medical device. These additions come as Cerebain readies itself for clini...
Source: Business Wire
Date: March, 16 2018 09:00
Cerebain Biotech to Initiate Search for Contract Research Organization
Cerebain Biotech (OTCQB: CBBT) today announced that the company intends to initiate the search process to partner with a Contract Research Organization (CRO). The search comes as Cerebain readies itself for clinical trials and the FDA application process in conjunction with the development a...
Source: Business Wire
Date: March, 01 2018 12:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CBBT.

About Cerebain Biotech Corp. (OTC: CBBT)

Logo for Cerebain Biotech Corp. (OTC: CBBT)

Cerebain Biotech Corp. was incorporated on December , under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company s business revolves around the discovery of products for the treatment of Alzheimer s disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.




Current Management

  • Eric Clemons / CEO
  • Wesley Tate / CFO
  • Eric Clemons /
  • Wesley Tate /

Current Share Structure

  • Market Cap: $1,325,902 - 03/09/2018
  • Authorized: 249,000,000 - 02/28/2018
  • Issue and Outstanding: 8,839,347 - 02/28/2018
  • Float: 2,347,210 - 09/27/2016


Recent Filings from (OTC: CBBT)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 06 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 09 2017
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: October, 03 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: September, 15 2017



Daily Technical Chart for (OTC: CBBT)

Daily Technical Chart for (OTC: CBBT)

Stay tuned for daily updates and more on (OTC: CBBT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CBBT)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CBBT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CBBT and does not buy, sell, or trade any shares of CBBT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: